MedTrace Logo

Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery

NCT06913595 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-26

No results posted yet for this study

Summary

Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant

Conditions

  • Deep Venous Thrombosis

Interventions

DRUG

Direct Oral Anticoagulant.

Direct Oral Anticoagulant AFTER BARIATRIC SURGERY

DRUG

Low Molecular Weight Heparine

Low molecular weight heparin after bariatric surgery

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • mohammed elshwadfy · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-25
Primary Completion
2025-10-25
Completion
2025-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06913595 on ClinicalTrials.gov